FORMULATION AND DEVELOPMENT OF IN SITU FORMING GEL FOR THE TREATMENT OF ORAL THRUSH

  • Akshay Kumar S Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.
  • Vishal Gupta N Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.
  • Gowda Dv Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.
  • Praveen Sivadasu Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.

Abstract

Objective: The objective of the present work was to develop an in situ gel composed of Pluronic F-127, Carbopol 934, and methylparaben and loaded with fluconazole using DoE software to sustain the delivery of drug in the buccal cavity.

Methods: In situ gels were prepared by temperature-induced method, by employing DoE and characterized by Fourier transform infrared (FTIR), differential scanning calorimeter (DSC), and evaluated for gelation temperature, gelation time, adhesive force, and in vitro diffusion studies.

Results: Both FTIR and DSC studies suggested that there were no chemical interactions present between both drug and polymers. The formulated gels S1, S3, and S9 showed gelation at a body temperature. The viscosity, gel strength, and mucoadhesive force for the formulated in situ gels were found to be within the ranges of 375–738 cps, 35–62 s, and 4650–5210.32 dynes/cm2, respectively. The in vitro diffusion studies indicated that optimized in situ gel S3 exhibited the improved ability to sustain the drug compared to other formulations.

Conclusion: Thus, developed in situ gel system was determined to be effective in terms of eradication of oral thrush.

Keywords: In situ gel, Pluronic F-127, Carbopol 980, Fluconazole, Oral thrush.

Author Biography

Akshay Kumar S, Department of Pharmaceutics, JSS College of Pharmacy, Sri Shivarathreeshwara Nagara, Mysuru, JSS Academy of Higher Education and Research, JSS Medical Institutions Campus, Sri Shivarathreeshwara Nagara, Mysuru – 570015, Karnataka, India.
Professor

References

1. Harish NM, Prabhu P, Charyulu RN, Gulzar MA, Subrahmanyam EV. Formulation and evaluation of in situ gels containing clotrimazole for oral candidiasis. Indian J Pharm Sci 2009;71:421-7.
2. Chattopadhyay A, Caplan DJ, Slade GD, Shugars DC, Tien HC, Patton LL, et al. Incidence of oral candidiasis and oral hairy leukoplakia in HIV-infected adults in north Carolina. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99:39-47.
3. Melo NR, Taguchi H, Culhari VP, Kamei K, Mikami Y, Smith SN, et al. Oral candidiasis of HIV-infected children undergoing sequential HIV therapies. Med Mycol 2009;47:149-56.
4. Chang JY, Oh YK, Kong HS, Kim EJ, Jang DD, Nam KT, et al. Prolonged antifungal effects of clotrimazole-containing mucoadhesive thermosensitive gels on vaginitis. J Control Release 2002;82:39-50.
5. Ning MY, Guo YZ, Pan HZ, Yu HM, Gu ZW. Preparation and evaluation of proliposomes containing clotrimazole. Chem Pharm Bull 2005;53:620-4.
6. Zhidong L, Jaiwei L, Shufang N, Hui L, Pingtian D, Weisan P. Study of an alginate/HPMC based in situ gelling ophthalmic delivery system for gatifloxacin. Int J Pharm 2006;315:12-7.
7. Pandey P, Dahiya M. A brief review on inorganic nanoparticles. J Crit Rev 2016;3:18-26.
8. Ekiert RJ, Krzek J, Talik P. Chromatographic and electrophoretic techniques used in the analysis of triazole antifungal agents-a review Talanta 2010;82:1090-100.
9. Rao MR, Shelar SU, Yunusi A. Controlled release floating oral in situ gel of Itopride hydrochloride using pH sensitive polymer. Int J Pharm Pharm Sci 2014;6:338-43.
10. Patil PR, Salve VK, Thorat RU, Puranik PK, Khadabadi SS. Modern encroachment and provocation in nasal drug delivery system. Int J Pharm Sci Res 2013;4:2569-75.
11. Shaikh R, Shah S, Patel K, Patel B, Patel P. A review on polymers used in in-situ drug delivery systems. Int J Pharm Res Sci 2012;1:17-31.
12. Miyazaki S, Suzuki S, Kawasaki N, Endo K, Takahashi A, Attwood D. In situ gelling xyloglucan formulations for sustained release ocular delivery of pilocarpine hydrochloride. Int J Pharm 2001;229:29-36.
13. Maheswaran A, Padmavathy J, Nandhini V, Saravanan D, Angel P. Formulation and evaluation of floating oral in situ gel of diltiazem hydrochloride. Int J App Pharm 2017;9:50-3.
14. Saudagar RB, Khandbahale SV. Formulation development and evaluation of nasal in-situ gel of fluticasone propionate. Int J Curr Pharm Res 2017;9:45-54.
15. Walewijk A, Cooper-White JJ, Dunstan DE. Adhesion measurements between alginate gel surfaces via texture analysis. Food Hydrocoll 2008;22:91-6.
16. Deshkar SS, Patil AT, Poddar SS. Development of thermosensitive gel of fluconazole for vaginal candidiasis. Int J Pharm Pharm Sci 2016;8:391-8.
17. Galgatte UC, Kumbhar AB, Chaudhari PD. Development of in situ gel for nasal delivery: Design, optimization, in vitro and in vivo evaluation. Drug Deliv 2014;21:62-73.
18. Sanjay R, Jigar V, Vijay P, Dhaval R. A review on in-situ polymeric drug delivery system. Indian J Drug Formul Res 2011;2:143-68.
Statistics
127 Views | 291 Downloads
Citatons
How to Cite
S, A. K., V. G. N, G. Dv, and P. Sivadasu. “FORMULATION AND DEVELOPMENT OF IN SITU FORMING GEL FOR THE TREATMENT OF ORAL THRUSH”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 11, no. 8, Aug. 2018, pp. 342-6, doi:10.22159/ajpcr.2018.v11i8.26190.
Section
Original Article(s)